1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
Dogan, A. Embryonic stem cells in development and regenerative medicine. Adv. Exp. Med. Biol. 2018, 1079, 1–15.
Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined
factors. Cell 2006, 126, 663–676. [CrossRef]
Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from
adult human fibroblasts by defined factors. Cell 2007, 131, 861–872. [CrossRef] [PubMed]
Wang, T.; Chen, C.; Larcher, L.M.; Barrero, R.A.; Veedu, R.N. Three decades of nucleic acid aptamer technologies: Lessons learned,
progress and opportunities on aptamer development. Biotechnol. Adv. 2019, 37, 28–50. [CrossRef] [PubMed]
Ueki, R.; Atsuta, S.; Ueki, A.; Hoshiyama, J.; Li, J.; Hayashi, Y.; Sando, S. DNA aptamer assemblies as fibroblast growth factor
mimics and their application in stem cell culture. Chem. Commun. 2019, 55, 2672–2675. [CrossRef]
Shinji, S.; Umezawa, K.; Nihashi, Y.; Nakamura, S.; Shimosato, T.; Takaya, T. Identification of the myogenetic oligodeoxynucleotides (myoDNs) that promote differentiation of skeletal muscle myoblasts by targeting nucleolin. Front. Cell Dev. Biol. 2021,
8, 616706. [CrossRef] [PubMed]
Nakamura, S.; Yonekura, S.; Shimosato, T.; Takaya, T. Myogenetic oligodeoxynucleotide (myoDN) recovers the differentiation of
skeletal muscle myoblasts deteriorated by diabetes mellitus. Front. Physiol. 2021, 12, 679152. [CrossRef] [PubMed]
Nihashi, Y.; Shinji, S.; Umezawa, K.; Shimosato, T.; Ono, T.; Kagami, H.; Takaya, T. Myogenetic oligodeoxynucleotide complexed
with berberine promotes differentiation of chicken myoblasts. Anim. Sci. J. 2021, 92, e13597. [CrossRef]
Nihashi, Y.; Yamamoto, M.; Shimosato, T.; Takaya, T. Myogenetic oligodeoxynucleotide restores differentiation and reverses
inflammation of myoblasts aggravated by cancer-conditioned medium. Muscles 2022, 1, 111–120. [CrossRef]
Nohira, S.; Shinji, S.; Nakamura, Y.; Nihashi, Y.; Shimosato, T.; Takaya, T. Myogenetic oligodeoxynucleotides as anti-nucleolin
aptamers inhibit the growth of embryonal rhabdomyosarcoma cells. Biomedicines 2022, 10, 2691. [CrossRef]
Jia, W.; Yao, Z.; Zhao, J.; Guan, Q.; Gao, L. New perspectives of physiological and pathological functions of nucleolin (NCL). Life
Sci. 2017, 186, 1–10. [CrossRef] [PubMed]
Laurincik, J.; Bjerregaard, B.; Strejcek, F.; Rath, D.; Niemann, H.; Rosenkranz, C.; Ochs, R.L.; Maddox-Hyttel, P. Nucleolar
ultrastructure and protein allocation in in vitro produced porcine embryos. Mol. Reprod. Dev. 2004, 68, 327–334. [CrossRef]
[PubMed]
Li, H.; Wang, B.; Yang, A.; Lu, R.; Wang, W.; Zhou, Y.; Shi, G.; Kwon, S.W.; Zhao, Y.; Jin, Y. Ly-1 antibody reactive clone is an
important nucleolar protein for control of self-renewal and differentiation in embryonic stem cells. Stem Cells 2009, 27, 1244–1254.
[CrossRef] [PubMed]
Johansson, H.; Svensson, F.; Runnberg, R.; Simonsson, T.; Simonsson, S. Phosphorylated nucleolin interacts with translationally
controlled tumor protein during mitosis and with Oct4 during interphase in ES cells. PLoS ONE 2010, 5, e13678. [CrossRef]
Yang, A.; Shi, G.; Zhou, C.; Lu, R.; Li, H.; Sun, L.; Jin, Y. Nucleolin maintains embryonic stem cell self-renewal by suppression of
p53 protein-dependent pathway. J. Biol. Chem. 2011, 286, 43370–43382. [CrossRef]
Percharde, M.; Lin, C.J.; Yin, Y.; Guan, J.; Peixoto, G.A.; Bulut-Karslioglu, A.; Biechele, S.; Huang, B.; Shen, X.; Ramalho-Santos, M.
A LINE1-nucleolin partnership regulates early development and ESC identity. Cell 2018, 174, 391–405. [CrossRef]
Int. J. Mol. Sci. 2023, 24, 14380
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
16 of 17
Okita, K.; Ichisaka, T.; Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 488, 313–317.
[CrossRef]
Hidaka, K.; Lee, J.K.; Kim, H.S.; Ihm, C.H.; Iio, A.; Ogawa, M.; Nishikawa, S.; Kodama, I.; Morisaki, T. Chamber-specific
differentiation of Nkx2.5-positive cardiac precursor cells from murine embryonic stem cells. FASEB J. 2003, 17, 740–742. [CrossRef]
Kaichi, S.; Takaya, T.; Morimoto, T.; Sunagawa, Y.; Kawamura, T.; Ono, K.; Shimatsu, A.; Baba, S.; Heike, T.; Nakahata, T.; et al.
Cyclin-dependent kinase 9 forms a complex with GATA4 and is involved in the differentiation of mouse ES cells into cardiomyocytes. J. Cell. Physiol. 2011, 226, 248–254. [CrossRef]
Narita, S.; Unno, K.; Kato, K.; Okuno, Y.; Sato, Y.; Tsumura, Y.; Fujikawa, Y.; Shimizu, Y.; Hayashida, R.; Kondo, K.; et al. Direct
reprogramming of adult adipose-derived regenerative cells toward cardiomyocytes using six transcriptional factors. iScience
2022, 25, 104651. [CrossRef]
Mercola, M.; Ruiz-Lozano, P.; Schneider, M.D. Cardiac muscle regeneration: Lessons from development. Genes. Dev. 2011, 25,
299–309. [CrossRef] [PubMed]
Nusse, R.; Clevers, H. Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell 2017, 169, 989–999.
Mazzotta, S.; Neves, C.; Bonner, R.J.; Bernardo, A.S.; Docherty, K.; Hoppler, S. Distinctive roles of canonical and noncanonical
Wnt signaling in human embryonic cardiomyocyte development. Stem Cell Rep. 2016, 7, 764–776. [CrossRef] [PubMed]
Schmeckpeper, J.; Verma, A.; Yin, L.; Beigi, F.; Zhang, L.; Payne, A.; Zhang, Z.; Pratt, R.E.; Dzau, V.J.; Mirotsou, M. Inhibition of
Wnt6 by Sfrp2 regulates adult cardiac progenitor cell differentiation by differential modulation of Wnt pathways. J. Mol. Cell.
Cardiol. 2015, 85, 215–225. [CrossRef] [PubMed]
Mukherjee, S.; Luedeke, D.M.; McCoy, L.; Iwafuchi, M.; Zorn, A.M. SOX transcription factors direct TCF-independent WNT/betacatenin responsive transcription to govern cell fate in human pluripotent stem cells. Cell Rep. 2022, 40, 111247. [CrossRef]
[PubMed]
Naito, T.A.; Shiojima, I.; Akazawa, H.; Hidaka, K.; Morisaki, T.; Kikuchi, A.; Komuro, I. Developmental stage-specific biphasic
roles of Wnt/β-catenin signaling in cardiomyogenesis and hematopoiesis. Proc. Natl. Acad. Sci. USA 2006, 103, 19812–19817.
[CrossRef]
Frey, N.; Katus, H.A.; Olson, E.N.; Hill, J.A. Hypertrophy of the heart: A new therapeutic target? Circulation 2004, 109, 1580–1589.
[CrossRef]
Lei, H.; Hu, J.; Sun, K.; Xu, D. The role and molecular mechanism of epigenetics in cardiac hypertrophy. Heart Fail. Rev. 2020, 26,
1505–1514. [CrossRef]
D’Amato, G.; Luxan, G.; de la Pmpa, J.L. Notch signalling in ventricular chamber development and cardiomyopathy. FEBS J.
2016, 283, 4223–4237. [CrossRef]
Tajbakhsh, S. Skeletal muscle stem cells in developmental versus regenerative myogenesis. J. Intern. Med. 2009, 266, 372–389.
[CrossRef]
Mizuno, Y.; Chang, H.; Umeda, K.; Niwa, A.; Iwasa, T.; Awaya, T.; Fukada, S.; Yamamoto, H.; Yamanaka, S.; Nakahata, T.; et al.
Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J. 2010, 24, 2245–2253.
[CrossRef]
Mummery, C.L.; Zhang, J.; Ng, E.S.; Elliott, D.A.; Elefanty, A.G.; Kamp, T.J. Differentiation of human embryonic stem cells and
induced pluripotent stem cells to cardiomyocytes: A methods overview. Circ. Res. 2012, 111, 344–358. [CrossRef] [PubMed]
Reister, S.; Mahotka, C.; van den Hofel, N.; Grinstein, E. Nucleolin promotes Wnt signaling in human hematopoietic
stem/progenitor cells. Leukemia 2019, 33, 1052–1054. [CrossRef] [PubMed]
Yamamoto, M.; Miyoshi, M.; Morioka, K.; Mitani, T.; Takaya, T. Anti-nucleolin aptamer, iSN04, inhibits the inflammatory
responses in C2C12 myoblasts by modulating the β-catenin/NF-κB signaling pathway. Biochem. Biophys. Res. Commun. 2023, 664,
1–8. [CrossRef]
Liu, J.J.; Shentu, L.M.; Ma, N.; Wang, L.Y.; Zhang, G.M.; Sun, Y.; Wang, Y.; Li, J.; Mu, Y.L. Inhibition of NF-κB and Wnt/βcatenin/GSK3β signaling pathways ameliorates cardiomyocyte hypertrophy and fibrosis in streptozotocin (STZ)-induced type 1
diabetic rats. Curr. Med. Sci. 2020, 40, 35–47. [CrossRef]
Nihashi, Y.; Miyoshi, M.; Umezawa, K.; Shimosato, T.; Takaya, T. Identification of a novel osteogenetic oligodeoxynucleotide
(osteoDN) that promotes osteoblast differentiation in a TLR9-independent manner. Nanomaterials 2022, 12, 1680. [CrossRef]
Babicki, S.; Arndt, D.; Marcu, A.; Liang, Y.; Grant, J.R.; Maciejewski, A.; Wishart, D.S. Heatmapper: Web-enabled heat mapping
for all. Nucleic Acid. Res. 2016, 44, W147–W153. [CrossRef] [PubMed]
Huang, D.W.; Sherman, B.T.; Lempicki, R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics
resources. Nat. Protoc. 2009, 4, 44–57. [CrossRef]
Takaya, T.; Kawamura, T.; Morimoto, T.; Ono, K.; Kita, T.; Shimatsu, A.; Hasegawa, K. Identification of p300-targeted acetylated
residues in GATA4 during hypertrophic responses in cardiac myocytes. J. Biol. Chem. 2008, 283, 9828–9835. [CrossRef]
Liu, W.; Brown, K.; Legros, S.; Foley, A.C. Nodal mutant eXtraembryonic ENdoderm (XEN) stem cells upregulate markers for
the anterior visceral endoderm and impact the timing of cardiac differentiation in mouse embryoid bodies. Biol. Open 2012, 1,
208–219. [CrossRef]
Int. J. Mol. Sci. 2023, 24, 14380
41.
42.
17 of 17
Sakurai, H.; Okawa, Y.; Inami, Y.; Nishio, N.; Isobe, K. Paraxial mesodermal progenitors derived from mouse embryonic stem
cells contribute to muscle regeneration via differentiation into muscle satellite cells. Stem Cells 2008, 26, 1865–1873. [CrossRef]
[PubMed]
Wang, T.; McDonald, C.; Petrenko, N.B.; Leblanc, M.; Wang, T.; Giguere, V.; Evans, R.M.; Patel, V.V.; Pei, L. Estrogen-related
receptor α (ERRα) and ERRγ are essential coordinators of cardiac metabolism and function. Mol. Cell. Biol. 2015, 35, 1281–1298.
[CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual
author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to
people or property resulting from any ideas, methods, instructions or products referred to in the content.
...
論文の公開元へ
